Assessment of Interactions Between Methamphetamine and Aripiprazole - 1

National Institutes of Health (NIH)

Status and phase: Unknown; Phase 1

Conditions: Amphetamine-Related Disorders

Treatments: Drug: Aripiprazole

Study type: Interventional

Funder types: NIH

Identifiers

NCT00089440

NIDA-MDS-0002-1

Details and patient eligibility

About

The purpose of this study is to assess the interactions between intravenous methamphetamine and aripiprazole.

Full description

This is a double-blind, placebo-controlled human laboratory clinical pharmacology study to assess potential interactions between intravenous d-methamphetamine infusion and treatment with oral aripiprazole.

Sex: All

Ages: 18 to 45 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Must meet DSM-4 criteria for methamphetamine abuse or dependence and are non-treatment seeking.
• Ability to verbalize understanding of the consent form, able to provide written informed consent, and verbalize willingness to complete study procedures.

Exclusion criteria

• Please contact the site for more information.